N. Moins

发表

Uptake of technetium-99m-teboroxime in cultured myocardial cells: comparison with thallium-201 and technetium-99m-sestamibi.

J. Maublant, A. Veyre, N. Moins, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Secondary ion mass spectrometry as a tool for investigating radiopharmaceutical distribution at the cellular level: the example of I-BZA and (14)C-I-BZA.

E. Hindié, A. Veyre, N. Moins, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Secondary Ion Mass Spectrometry as a Tool for Investigating Radiopharmaceutical Distribution at the Cellular Level: The Example of I-BZA and 14C-I-BZA

E. Hindié, A. Veyre, N. Moins, 2005 .

123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging

A. Veyre, N. Moins, J. Papon, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

Internal dosimetry through GATE simulations of preclinical radiotherapy using a melanin-targeting ligand

N. Moins, J. Papon, J. Chezal, 2014, Physics in medicine and biology.

High resolution magic angle spinning NMR spectroscopy used to investigate the ability of drugs to bind to synthetic melanin.

N. Moins, J. Madelmont, M. Moreau, 2005, Pigment cell research.

Validity of a model of cultured myocardial cells for assessment of cardioplegia

J. Maublant, A. Veyre, N. Moins, 1997, Cell Biology and Toxicology.

Design, synthesis and preliminary biological evaluation of acridine compounds as potential agents for a combined targeted chemo-radionuclide therapy approach to melanoma.

J. Maublant, C. Lartigue, N. Moins, 2008, Bioorganic & medicinal chemistry.

Synthesis, radioiodination and in vivo screening of novel potent iodinated and fluorinated radiotracers as melanoma imaging and therapeutic probes.

N. Moins, J. Papon, J. Madelmont, 2013, European journal of medicinal chemistry.

Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [18F]ICF01006, a highly promising melanoma PET tracer

N. Moins, J. Chezal, E. Miot-Noirault, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Melanin affinity of N-(2-diethylaminoethyl)-4-iodobenzamide, an effective melanoma imaging agent

A. Veyre, N. Moins, J. Papon, 2002, Melanoma research.

Comparison between technetium-99m-sestamibi and hydrogen-3-daunomycin myocardial cellular retention in vitro.

J. Maublant, N. Moins, P. Verrelle, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Evaluation of two 125I-radiolabeled acridine derivatives for Auger-electron radionuclide therapy of melanoma

N. Moins, J. Papon, J. Chezal, 2014, Investigational New Drugs.

Evaluation of new iodinated acridine derivatives for targeted radionuclide therapy of melanoma using 125I, an Auger electron emitter

N. Moins, J. Papon, J. Madelmont, 2011, Investigational New Drugs.

Comparative 99mTc-sestamibi and 3H-daunomycin uptake in human carcinoma cells: relation to the MDR phenotype and effects of reversing agents.

J. Maublant, N. Moins, P. Verrelle, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Longitudinal profiling of articular cartilage degradation in osteoarthritis by high-resolution magic angle spinning 1H NMR spectroscopy: experimental study in the meniscectomized guinea pig model.

J. Maublant, N. Moins, J. Papon, 2009, Journal of proteome research.

Early detection and monitoring of cartilage alteration in the experimental meniscectomised guinea pig model of osteoarthritis by 99mTc-NTP 15-5 scintigraphy

L. Sarry, N. Moins, J. Madelmont, 2007, European Journal of Nuclear Medicine and Molecular Imaging.

Melanoma affinity in mice and immunosuppressed sheep of [(125)I]N-(4-dipropylaminobutyl)-4-iodobenzamide, a new targeting agent.

N. Moins, J. Papon, J. Madelmont, 2008, Nuclear medicine and biology.

Evaluation of radiolabeled (hetero)aromatic analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and targeted radionuclide therapy of melanoma.

J. Maublant, C. Lartigue, N. Moins, 2008, Journal of medicinal chemistry.

Synthesis, characterization and comparative biodistribution study of a new series of p-iodine-125 benzamides as potential melanoma imaging agents.

A. Veyre, N. Moins, J. Papon, 2001, Nuclear medicine and biology.

B16 melanoma secretomes and in vitro invasiveness: syntenin as an invasion modulator

N. Moins, J. Chezal, M. Bonnet, 2010, Melanoma research.

Proteomic studies of B16 lines: involvement of annexin A1 in melanoma dissemination.

J. Maublant, N. Moins, J. Papon, 2009, Biochimica et biophysica acta.

Antineoplastic potency of arylchloroethylurea derivatives in murine colon carcinoma

N. Moins, J. Madelmont, E. Miot-Noirault, 2004, Investigational New Drugs.

Evaluation in mice of some iodinated melanoma imaging agents using cryosectioning and multi-wire proportional counting

A. Veyre, N. Moins, J. Papon, 1999, European Journal of Nuclear Medicine.

Bépridil a new effector of oxidative phosphorylations.

N. Moins, A. Younès, M. Habert, 1977, Biochimie.

A boronated benzamide as melanoma-seeking agent

N. Moins, J. Papon, M. Moreau, 1997 .

The use of [(125)I] scintigraphic in vivo imaging in melanoma-bearing mice for a rapid prescreening of vectors to melanoma tissue.

J. Maublant, N. Moins, J. Papon, 2009, Cancer biotherapy & radiopharmaceuticals.

Synthesis, radiolabeling, and preliminary evaluation in mice of some (N-diethylaminoethyl)-4-iodobenzamide derivatives as melanoma imaging agents.

J. Boire, N. Moins, J. Papon, 1995, Nuclear medicine and biology.

Paradoxal pharmacologic effects observed withβ-blocker agents on cardiac cells in culture

N. Moins, P. Gachon, M. Renoux, 1991, In Vitro Cellular & Developmental Biology - Animal.

Uptake in melanoma cells of N-(2-diethylaminoethyl)-2-iodobenzamide (BZA2), an imaging agent for melanoma staging: relation to pigmentation.

A. Veyre, N. Moins, J. Papon, 2005, Nuclear medicine and biology.

Comparison of verapamil and bepridil, two slow channel inhibitors, in protection against calcium-induced arrhythmias

N. Moins, P. Gachon, P. Duchêne-Marullaz, 1986, Naunyn-Schmiedeberg's Archives of Pharmacology.

Synthesis, radiofluorination, and in vivo evaluation of novel fluorinated and iodinated radiotracers for PET imaging and targeted radionuclide therapy of melanoma.

N. Moins, J. Madelmont, J. Chezal, 2013, Journal of medicinal chemistry.

In vivo efficacy of melanoma internal radionuclide therapy with a 131I‐labelled melanin‐targeting heteroarylcarboxamide molecule

F. Penault-Llorca, N. Moins, J. Papon, 2013, International journal of cancer.

Promising pre-clinical validation of targeted radionuclide therapy using a [131I] labelled iodoquinoxaline derivative for an effective melanoma treatment

Frédérique Penault-Llorca, F. Penault-Llorca, N. Moins, 2009 .

Targeted radionuclide therapy of melanoma: Anti‐tumoural efficacy studies of a new 131I labelled potential agent

J. Maublant, F. Penault-Llorca, N. Moins, 2009, International journal of cancer.

Anti‐melanoma efficacy of internal radionuclide therapy in relation to melanin target distribution

F. Penault-Llorca, N. Moins, J. Papon, 2010, Pigment cell & melanoma research.

Development of a high-performance liquid chromatographic method for the determination of a new potent radioiodinated melanoma imaging and therapeutic agent.

N. Moins, J. Papon, J. Madelmont, 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Theranostic Approach for Metastatic Pigmented Melanoma Using ICF15002, a Multimodal Radiotracer for Both PET Imaging and Targeted Radionuclide Therapy1

N. Moins, F. Mishellany, J. Chezal, 2016, Neoplasia.

First Preclinical Imaging of Primary Cartilage Neoplasm and Its Local Recurrence Using 99mTc-NTP 15-5 Radiotracer

Serge Askienazy, Jean Maublant, J. Maublant, 2009, Journal of Nuclear Medicine.

Single photon emission computed tomography/positron emission tomography imaging and targeted radionuclide therapy of melanoma: new multimodal fluorinated and iodinated radiotracers.

R. Boisgard, B. Tavitian, N. Moins, 2011, Journal of medicinal chemistry.

Single Photon Emission Computed Tomography / Positron Emission Tomography Imaging and Targeted Radionuclide Therapy ofMelanoma : NewMultimodal Fluorinated and IodinatedRadiotracers

B. Tavitian, N. Moins, J. Papon, 2011 .

Cultured neonatal rat cardiomyocytes and 99mTc-sestamibi to assess the direct effects of cardioplegia.

J. Maublant, A. Veyre, N. Moins, 1998, Cardiovascular surgery.

Myocardial uptake of thallium-201 diethyldithiocarbamate (201TI-DDC) in cultured heart cells and in humans

J. Maublant, A. Veyre, N. Moins, 1987, European Journal of Nuclear Medicine.

Multi-organ functional imaging with thallium-201: a new noninvasive method for rapid assessment of vasoactive drugs.

J. Maublant, N. Moins, P. Gachon, 1982, Journal of pharmacological methods.

Hexakis (2-methoxy isobutylisonitrile) technetium-99m and thallium-201 chloride: uptake and release in cultured myocardial cells.

J. Maublant, N. Moins, P. Gachon, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Comparative Study of Vascular Effects of Four Calcium Antagonists Using a Multi‐Organ Functional Imaging Technique with Thallium‐201

J. Maublant, N. Moins, P. Gachon, 1983, Journal of cardiovascular pharmacology.

Distribution of I-BZA (N-2-diethylaminoethyl-4-iodobenzamide) in grafted melanoma and normal skin: a study by secondary ion mass spectroscopy.

E. Hindié, A. Veyre, N. Moins, 2001, Cellular and molecular biology.

First in Vivo SPECT Imaging of Mouse Femorotibial Cartilage Using 99mTc-NTP 15-5

J. Maublant, N. Moins, J. Madelmont, 2008, Molecular Imaging.

Effects of the ionophore grisorixin on myocardial function and metabolism in isolated perfused working rat heart under normoxic and hypoxic conditions.

N. Moins, P. Gachon, M. Renoux, 1986, Canadian journal of physiology and pharmacology.

Assessment of drugs by functional imaging of thallium-201 distribution in the dog.

J. Maublant, N. Moins, P. Gachon, 1981, Journal of Nuclear Medicine.

Establishment of IPC 227 cells as human xenografts in rabbits: a model of uveal melanoma

N. Moins, D. Morvan, J. Papon, 2000, Melanoma research.

Synthesis, in vitro binding and biodistribution in B16 melanoma-bearing mice of new iodine-125 spermidine benzamide derivatives.

N. Moins, J. Papon, J. Madelmont, 2005, Nuclear medicine and biology.

Quantification of infarct size in the dog by thallium-201 single photon emission transaxial tomography (SPETT).

J. Maublant, N. Moins, P. Gachon, 1983, European heart journal.

[Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma].

A. Veyre, N. Moins, M. D’Incan, 2004, Journal francais d'ophtalmologie.

P29 New heteroaromatic compounds for a targeted melanoma therapy: factors modulating subcellular distribution

N. Moins, J. Papon, J. Madelmont, 2010 .